Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,264 | 642 | 95.9% |
| Travel and Lodging | $406.69 | 2 | 3.8% |
| Education | $36.90 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,205 | 92 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,088 | 106 | $0 (2024) |
| MDD US Operations, LLC | $684.37 | 9 | $0 (2024) |
| LivaNova USA, Inc. | $669.84 | 3 | $0 (2019) |
| Allergan, Inc. | $634.44 | 64 | $0 (2022) |
| ACADIA Pharmaceuticals Inc | $566.40 | 47 | $0 (2024) |
| Biogen, Inc. | $503.87 | 20 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $493.87 | 29 | $0 (2017) |
| UCB, Inc. | $366.39 | 27 | $0 (2024) |
| GENZYME CORPORATION | $356.77 | 19 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,391 | 129 | MDD US Operations, LLC ($649.86) |
| 2023 | $1,525 | 105 | AbbVie Inc. ($367.37) |
| 2022 | $1,515 | 89 | ACADIA Pharmaceuticals Inc ($206.58) |
| 2021 | $725.06 | 56 | Novartis Pharmaceuticals Corporation ($196.88) |
| 2020 | $726.63 | 50 | Allergan, Inc. ($137.15) |
| 2019 | $1,658 | 71 | LivaNova USA, Inc. ($669.84) |
| 2018 | $811.61 | 57 | Allergan Inc. ($153.22) |
| 2017 | $1,356 | 90 | Sunovion Pharmaceuticals Inc. ($493.87) |
All Payment Transactions
647 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $1.88 | General |
| Category: Neurology | ||||||
| 12/17/2024 | BANNER LIFE SCIENCES, LLC | BAFIERTAM (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Immune | ||||||
| 12/10/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Neurology | ||||||
| 11/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/18/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Neurology | ||||||
| 11/11/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: Neurology | ||||||
| 11/06/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $1.33 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/06/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $0.73 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/04/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $25.91 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $10.98 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/29/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Neurology | ||||||
| 10/23/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/22/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/21/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Immunology | ||||||
| 10/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.70 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Neurology | ||||||
| 10/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.52 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.99 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 310 | 386 | $74,832 | $27,666 |
| 2022 | 5 | 288 | 366 | $68,490 | $28,251 |
| 2021 | 7 | 362 | 458 | $80,565 | $36,041 |
| 2020 | 10 | 446 | 531 | $92,055 | $33,138 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 150 | $24,000 | $11,239 | 46.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 112 | 136 | $16,320 | $8,336 | 51.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 33 | 34 | $9,520 | $3,209 | 33.7% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 12 | 26 | $12,272 | $2,458 | 20.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $4,560 | $1,679 | 36.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 17 | 24 | $8,160 | $745.26 | 9.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 158 | 213 | $34,080 | $17,524 | 51.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 54 | 65 | $7,800 | $3,664 | 47.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 35 | 35 | $9,800 | $3,520 | 35.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $6,270 | $2,497 | 39.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 19 | 31 | $10,540 | $1,045 | 9.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 164 | 230 | $36,800 | $20,608 | 56.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 111 | 128 | $15,480 | $7,540 | 48.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 32 | 32 | $8,960 | $3,287 | 36.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 18 | 18 | $5,130 | $2,173 | 42.4% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Facility | 2021 | 15 | 28 | $9,520 | $989.23 | 10.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 11 | 11 | $2,640 | $845.40 | 32.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 11 | 11 | $2,035 | $598.62 | 29.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 169 | 220 | $35,450 | $15,387 | 43.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 117 | 133 | $16,080 | $6,422 | 39.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 43 | 44 | $12,320 | $4,382 | 35.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 24 | 24 | $6,840 | $2,731 | 39.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 17 | 17 | $4,080 | $1,083 | 26.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 18 | 19 | $3,515 | $1,059 | 30.1% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Facility | 2020 | 16 | 25 | $8,500 | $912.91 | 10.7% |
About Dr. Caroline Stevens, DO
Dr. Caroline Stevens, DO is a Neurology healthcare provider based in Anderson, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/03/2010. The National Provider Identifier (NPI) number assigned to this provider is 1992028039.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Caroline Stevens, DO has received a total of $10,708 in payments from pharmaceutical and medical device companies, with $2,391 received in 2024. These payments were reported across 647 transactions from 62 companies. The most common payment nature is "Food and Beverage" ($10,264).
As a Medicare-enrolled provider, Stevens has provided services to 1,406 Medicare beneficiaries, totaling 1,741 services with total Medicare billing of $125,096. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Anderson, IN
- Active Since 03/03/2010
- Last Updated 10/22/2019
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1992028039
Products in Payments
- KESIMPTA (Drug) $763.92
- VNS Therapy (Device) $726.17
- Apokyn (Drug) $649.86
- NUPLAZID (Drug) $566.40
- BOTOX (Biological) $526.64
- APTIOM (Drug) $493.87
- NURTEC ODT (Drug) $414.24
- DUOPA (Drug) $331.04
- UBRELVY (Drug) $290.83
- TYSABRI (Biological) $265.00
- Aimovig (Biological) $199.45
- Briviact (Drug) $192.95
- Fycompa (Drug) $190.79
- LEMTRADA (Drug) $174.09
- QULIPTA (Drug) $167.82
- AUBAGIO (Drug) $146.55
- MAYZENT (Drug) $136.57
- ACTIVA (Device) $133.28
- VYEPTI (Biological) $129.73
- Duopa (Drug) $124.34
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Anderson
Marc Cohen, Md, MD
Neurology — Payments: $15,277
Dr. Judi Knowles, M.d, M.D
Neurology — Payments: $8,969
Mr. Dixon Cunningham, Md, MD
Neurology — Payments: $7,806
Dr. Paul Brill, M.d, M.D
Neurology — Payments: $6,757
Christopher Rocco, Md, MD
Neurology — Payments: $2,762
Kumar Patel, M.d, M.D
Neurology — Payments: $387.35